English | Español

Regulatory
+ Regulatory
Press release submission | Jun 2, 2022

US FDA accepts New Drug Application filed by Avillion for AstraZeneca's PT027 for the as-needed treatment or prevention of symptoms in asthma patients
+ Regulatory
Press release submission | Jun 1, 2022

Priothera Receives Fast Track Designation for mocravimod in Combination with Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Post Remission Therapy of Acute Myeloid Leukemia (AML) Patients
+ Community
Press release submission | May 31, 2022

Revolutionary Heart Therapy Offers Hope to Patients and Investors Alike
+ Technology/Innovation
Press release submission | May 31, 2022

Bezyl, Inc. and THREAD Form Strategic Partnership to Support the Mental Health of Clinical Trial Participants
+ Regulatory
Press release submission | May 27, 2022

Anti-competitive Drug Middlemen Practices Harming Patients, Payers, and Pharmacies, APCI Tells FTC
+ Technology/Innovation
Press release submission | May 26, 2022

Caris Life Sciences to Showcase Extensive Research with Leading Cancer Centers Reflecting Its Commitment to Improving Outcomes for Patients at ASCO 2022
+ Technology/Innovation
Press release submission | May 26, 2022

New Research Demonstrates Genetic Information Can Transform Cancer Care, Guidelines Remain a Barrier to Patient Access
+ Regulatory
Press release submission | May 25, 2022

Servier Announces FDA Approval of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine for Patients with Newly Diagnosed IDH1-mutated Acute Myeloid Leukemia

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation